Subscription details
The IPO, which was opened on September 25 and closed on September 29, was subscribed to a total of 1.28 times. The part of the non-institutional investor (NII) raised a stronger question 1.63 times, while the retail segment saw filled interest on just 0.35 times subscription.
The issue consisted of a new issue of RS 44.75 Crore and an offer for sale (OFS) from RS 4.51 Crore. The proceeds will be used for working capital, expansion of the shop-in-shop (SIS) model of the company and other business purposes.
About the company
Earkart is a HealthTech platform that specializes in hearing aids and supporting devices. The product range includes several types of modern hearing aids-receiver-in-canal (RIC), Invisible (IIC), rear-ear (BTE), in-the-ear (ite) and full-in-channel (CIC).
The company also distributes folding hikers and educational material for the physically challenged. It is a registered supplier of the Alimco schedule of the government under the Ministry of Social Justice and Empowerment.
Financial
Earkart placed a robust growth in FY25, with a turnover of 35% to RS 43.2 Crore and the net profit that is more than doubling to RS 6.9 Crore, compared to RS 3.1 Crore a year earlier. EBITDA rose to RS 9.8 Crore.
With a flat GMP and lukewarm retail question, the list of Earkart can open without fireworks, making post-listing performance crucial for the sentiment of investors.
((Indemnification: Recommendations, suggestions, views and opinions of the experts are their own. These do not represent the views of economic times)
#Earkart #shares #today #debut #Check #GMP #list

